NCT01610219

Brief Summary

The number of youth with Type 2 diabetes (T2D) is rising in the population, which is a concerning public health trend. There has been little research testing ways to prevent the development of this disease in children who are at increased risk to develop T2D. This study tests a family treatment program that treats 4-8 year old children who are at risk for T2D because they are overweight and have a family history of the disease. Sixty at risk children and their parents were assigned to one of 2 treatment conditions. Half of the families (randomly determined) received an intensive family treatment program that trains parents in how to increase healthier foods choices and physical activity for themselves and their children using "behavior modification" strategies. Children receiving this treatment were allowed to taste new fruits and vegetables used a pedometer to record how far they walked every day, and were given a "tool box" of toys and interactive games which promoted physical activity. The other half of the families only received instruction about healthier choices, but received no behavioral modification strategies or physical activity promotion tools. Improvements in children's body weight, blood measures, and behavior patterns were measured after treatment ended (6 months) and then again after 12 months. The results may lead to a better understanding of how family members can positively influence young children's behaviors to help prevent T2D. The objective of proposed study was to test a family-based intervention designed to reduce excess body weight, improve metabolic and cardiovascular profile, and improve diet and physical activity levels in 4 - 8 year old youth who are "at risk" for T2D. This intervention was tested in a 2-arm randomized controlled clinical trial. Primary Hypotheses:

  1. 1.Compared to children receiving NPA, children receiving LMDP will show greater reductions in excess body weight, greater improvements in metabolic and cardiovascular measures, improved diet, increased physical activity, and reduced television viewing.
  2. 2.Greater reductions in child excess body weight will be associated with greater improvements in metabolic and cardiovascular measures.
  3. 3.Compared to parents receiving the NPA intervention, parents receiving the LMDP intervention will show greater reductions in BMI.
  4. 4.Greater improvements in parent BMI will be associated with greater improvements in child body composition, metabolic and cardiovascular measures, and behavioral outcomes.
  5. 5.Compared to families receiving the NPA intervention, families receiving the LMDP intervention will show an increase in the number of fruits and vegetables and lower energy density foods stored at home.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Aug 2008

Typical duration for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 30, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 1, 2012

Completed
Last Updated

June 1, 2012

Status Verified

May 1, 2012

Enrollment Period

2.4 years

First QC Date

May 30, 2012

Last Update Submit

May 31, 2012

Conditions

Outcome Measures

Primary Outcomes (12)

  • Body Mass Index (BMI)

    Change in BMI will be measured from baseline to end of intervention (6 months) and and also from 6 months to 12 months.

    Baseline, 6 and 12 months

  • BMI-z score

    Change in BMI-z score will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months.

    Baseline, 6 and 12 months

  • Percent overweight (% overweight)

    Change in percent overweight will be measured from baseline to end of treatment (6 months) and from 6 months to 12 months. Percent overweight is computed as a child's actual BMI minus the median BMI for a child of comparable sex and age, divided by 100.

    Baseline, 6 and 12 months

  • Waist Circumference(cm)

    Change in waist circumference (cm) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.

    Baseline, 6 and 12 months

  • Systolic Blood Pressure

    Change in systolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.

    Baseline, 6 and 12 months

  • Diastolic Blood Pressure (mm Hg)

    Change in diastolic blood pressure (mm Hg) will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.

    Baseline, 6 and 12 months

  • Pulse

    Change in resting pulse will be measured from baseline to end of treatment (6 months) and from end of treatment to 12 months.

    Baseline, 6 and 12 months

  • Physical Activity

    Change in physical activity was measured from baseline to end of treatment (6 months) and from end of treatment to 12 months using an accelerometer. The accelerometer measured light, moderate and moderate-to-vigorous actity over 7 days.

    Baseline, 6 and 12 months

  • Glucose

    Change in blood glucose levels were measured at baseline, 6 and 12 months.

    Baseline, 6 and 12 months

  • Insulin

    Change in plasma insulin levels from baseline to end of treatment (6 months) and from 6 months to 12 months.

    Baseline, 6 and 12 months

  • Change in HDL, LDL, Total Cholesterol and Triglycerides

    Change in lipid profile measures from baseline to end of treatment (6 months) and from 6 months to 12 months.

    Baseline, 6 and 12 months

  • Change in Dietary Intake

    Change in energy (kcals/day), protein, carbohydrate, fat, cholesterol, saturated fat and fiber intake.

    Baseline, 6 and 12 months

Secondary Outcomes (1)

  • Change in Parent BMI

    Baseline, 6 and 12 months

Study Arms (2)

Lifestyle Modification for Diabetes Prevention

ACTIVE COMPARATOR

Family based intervention utilizing Traffic Light Diet, self monitoring, parent behavioral skill training and tool kit of items promoting physical activity.

Behavioral: Lifestyle Modification for Type 2 Diabetes Prevention

Nutrition and Physical Activity

OTHER

Family based intervention providing education on healthy eating and physical activity but no behavioral skills training, goal setting, self monitoring or physical activity toolkit.

Other: Nutrition and Physical Activity

Interventions

Family based behavioral intervention utilizing Traffic Light Diet, self monitoring, goal setting, reinforcement and a tool kit containing physical activity-promoting items

Lifestyle Modification for Diabetes Prevention

This family based education program provided information on physical activity and healthy eating for parents and children.

Nutrition and Physical Activity

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age 4-8 years old
  • Age- and sex-specific BMI ≥95th percentile

You may not qualify if:

  • Children with serious medical conditions
  • Children who show signs of elevated psychopathology, as assessed by the Child Behavior Checklist (CBCL)
  • Children of parents with significantly elevated psychiatric disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania Center for Weight and Eating Disorders/Perelman School of Medicine

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity

Interventions

Nutritional StatusExercise

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaHealth StatusDemographyPopulation CharacteristicsMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Myles S Faith, Ph.D.

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 30, 2012

First Posted

June 1, 2012

Study Start

August 1, 2008

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

June 1, 2012

Record last verified: 2012-05

Locations